Patients with active psoriatic arthritis who have an inadequate response to TNF inhibitors, mainly those with elevated ...
Everyday Health on MSN
Psoriatic arthritis: What defines minimal disease activity?
This measure of how well controlled your psoriatic arthritis is can be used to guide treatment decisions.
A new study has found that biologic class and treatment sequencing influences psoriatic arthritis risk in patients with ...
The United States Food and Drug Administration recently approved Sotyktu TM (deucravacitinib) for the treatment of active psoriatic arthritis (PsA) among adults. Which of the statements below about ...
A comparative analysis identifies the top IL-23 inhibitors that were least likely to be associated with the development of ...
Combination therapy with multiple biologics may be on the horizon for patients with psoriatic arthritis, according to a ...
In the pivotal Phase 3 POETYK PsA clinical trials, Sotyktu demonstrated superiority compared with placebo at Week 16 across multiple endpoints, including skin and joint symptoms, with improvements in ...
European Commission approves Bristol Myers Squibb’s Sotyktu for the treatment of active psoriatic arthritis in adults: Princeton, New Jersey Monday, May 11, 2026, 15:00 Hrs [IST ...
Formulary preference will shift from Stelara to interchangeable Pyzchiva and Yesintek, aiming for low-friction conversion ...
Dragonfly Therapeutics, a clinical-stage biopharmaceutical company pioneering novel immunotherapies, today announced that the first patients have been successfully dosed subcutaneously (SC) with its ...
Discover how Phil Mickelson battled psoriatic arthritis while competing at the highest level of professional golf. From his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results